Funded Tech Companies
EpilepsyGTx
Wondering who backed EpilepsyGTx? HTH VC and UCL Technology Fund joined the equity holders in this life sciences company.
Company Overview
Company Name
EpilepsyGTx
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
Building 1000 Cambridge Research Park Beach Drive
Waterbeach Cambridgeshire, CB25 9PD
UK
Waterbeach Cambridgeshire, CB25 9PD
UK
Phone
Website
Email Address
Company Background Information
Overview
EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE). Focal epilepsy describes a group of disorders in which patients experience seizures that arise from a specific part of the brain1. Refractory epilepsy occurs when seizures persist despite trials of at least two tolerated and appropriately chosen antiseizure medicines2.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/24/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicolas Koebel
Chief Scientific Officer
Dimitri Kullmann
VP - R & D
Luiz Silva
Company Investors
- HTH VC
- UCL Technology Fund
Browse more funded tech companies:
Epigenomics AG | EpimAb Biotherapeutics
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs